Loading company…
Sapphiros develops diagnostic technologies and devices for consumer and clinical testing.
Sapphiros develops diagnostic technologies, including the SatioPatch platform for consumer testing and the GrapheneDx diagnostic device. Founded in 2021 by Namal Nawana, the company is based in Boston, US, and is led by CEO Mark Gladwell. KKR and an individual investor acquired the company in July 2021 for undisclosed terms.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in